FDA Announces Proposed Collection of Information for Blood and Blood Components Regulations

Summary

The Food and Drug Administration (FDA) has submitted a proposal to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, related to Current Good Manufacturing Practices and requirements for donation testing, donor notification, and 'Lookback' for blood and blood components.